Amarantus Competitors

Pink Sheets USA . 
Stock . Amarantus Bioscience Holdings
AMBS Stock  USD 0.0001  0.00  0.00%   
Amarantus Bioscience competes with Mesabi Trust, Nutanix, Morningstar Unconstrained, Thrivent High, and Via Renewables; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Amarantus Bioscience competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Amarantus Bioscience to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Amarantus Bioscience Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Amarantus Bioscience competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00009650.01
Details
Intrinsic
Valuation
LowRealHigh
0.000.000250.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Amarantus Bioscience. Your research has to be compared to or analyzed against Amarantus Bioscience's peers to derive any actionable benefits. When done correctly, Amarantus Bioscience's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Amarantus Bioscience.

Amarantus Bioscience Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Amarantus Bioscience and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Amarantus and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Amarantus Bioscience does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
RRTLX
+ 0.9
MSTSX
VIASP
+ 0.88
MSB
OSHDF
+ 0.87
VIASP
70082LAB3
+ 0.78
MSB
RRTLX
+ 0.77
LBHIX
OSHDF
+ 0.74
MSB
  
High negative correlations   
OSHDF
- 0.8
MSTSX
VIASP
- 0.64
MSTSX
OSHDF
- 0.63
RRTLX
OSHDF
- 0.62
AQUI
MSTSX
- 0.46
GTOR
MSTSX
- 0.45
MSB

Risk-Adjusted Indicators

There is a big difference between Amarantus Pink Sheet performing well and Amarantus Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Amarantus Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MSB  1.71  0.35  0.15  4.05  1.89 
(1.92)
 3.94 
(3.17)
 15.70 
NTNX  1.79  0.04  0.01  0.13  2.15 
(2.25)
 3.95 
(3.94)
 13.29 
GTOR  5.97  1.52  0.00 (2.31) 0.00 
 0.00 
 0.00 
 0.00 
 150.00 
AQUI  2.79 (1.43) 0.00 (19.59) 0.00 
 0.00 
 0.00 
 0.00 
 93.33 
MSTSX  0.54 (0.13) 0.00  7.97  0.00 
 0.00 
 1.03 
(1.02)
 7.08 
LBHIX  0.11 (0.02) 0.00 (1.13) 0.00 
 0.00 
 0.24 
(0.24)
 0.94 
VIASP  0.76  0.15  0.10 (1.06) 1.03 
(0.87)
 2.00 
(1.20)
 4.90 
RRTLX  0.28 (0.07) 0.00  3.40  0.00 
 0.00 
 0.48 
(0.56)
 3.47 
OSHDF  46.68  24.42  0.00 (1.47) 0.00 
 0.00 
 0.00 
 0.00 
 1,329 
70082LAB3  0.67  0.11  0.08 (0.53) 0.81 
(0.84)
 1.78 
(0.78)
 6.86 
All Fundamental Data

Amarantus Bioscience Competitive Analysis

The better you understand Amarantus Bioscience competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Amarantus Bioscience's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Amarantus Bioscience's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AMBS MSB NTNX GTOR AQUI MSTSX LBHIX VIASP RRTLX OSHDF
 0.00 
 0.0001 
Amarantus
 0.85 
 28.60 
Mesabi
 1.79 
 62.53 
Nutanix
 50.00 
 0.0001 
Ggtoor
 93.33 
 0.0004 
Aquagold
 0.19 
 10.83 
Morningstar
 0.24 
 4.21 
Thrivent
 0.17 
 23.58 
Via
 0.50 
 12.10 
RRTLX
 260.00 
 0.04 
Oshidori
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Very steady
Out of control
Out of control
Very steady
Very steady
Very steady
Very steady
Out of control
Market Performance
(90 Days Performance)
Good
Good
Insignificant
Modest
Very Weak
Very Weak
Very Weak
Strong
Very Weak
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Quite High
Low
Very Low
High
Average
Low
Low
Below Average
Low
Average
Current Valuation
(Equity Enterprise Value)
Under Valued
Under Valued
Over Valued
Fairly Valued
Over Valued
Under Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Sell
Strong Buy
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Hold
Buy
Strong Buy
Cautious Hold
Cautious Hold
Strong Hold
Strong Hold
Strong Hold
Strong Hold
Cautious Hold
Current Ratio
0.02
2.32
1.44
0.09
N/A
N/A
N/A
3.49
N/A
N/A
Net Asset
3.48 M
26.69 M
2.14 B
N/A
3.19 K
116.1 M
674.44 M
355.28 M
1.46 B
6.31 B
EBITDA
(20.79 M)
18.54 M
172.72 M
(3.03 M)
(727.69 K)
N/A
N/A
33.09 M
N/A
(3.49 B)
Operating Margin
N/A
0.56
0.0079
-44.98
N/A
N/A
N/A
-0.14
N/A
1.04
Five Year Return
N/A
11.27
N/A
N/A
N/A
7.5
2.89
8.97
0.0406
N/A
One Year Return
N/A
N/A
N/A
N/A
N/A
12.69
6.96
N/A
0.067
N/A
Beta
1.67
0.85
1.17
1.4
7.05
N/A
N/A
1.16
N/A
0.67
Number Of Employees
19
N/A
7.15 K
132
7
1
1
169
1
31
Three Year Return
N/A
N/A
N/A
N/A
N/A
6.47
2.41
N/A
0.0491
N/A
Cash Flow From Operations
(1.8 M)
14.61 M
672.93 M
(1.02 M)
(218.19 K)
N/A
N/A
12.7 M
N/A
499.26 M
Total Debt
20.72 M
1.96 M
684.6 M
553.69 K
N/A
N/A
N/A
135 M
N/A
N/A
Bond Positions Weight
N/A
N/A
N/A
N/A
N/A
22.72
92.23
N/A
14.43
N/A
Holdings Turnover
N/A
N/A
N/A
N/A
N/A
269.0
N/A
N/A
N/A
N/A
Return On Asset
N/A
0.68
0.0069
N/A
-5.5
N/A
N/A
-0.11
N/A
-0.46
Current Liabilities
15.83 M
5.68 M
212.76 M
507 K
794 K
N/A
N/A
N/A
N/A
N/A
Debt To Equity
0.84
1843368.0
967.9
956.5
N/A
N/A
N/A
0.69
N/A
N/A
Short Ratio
N/A
20.38
3.34
N/A
N/A
N/A
N/A
0.7
N/A
N/A
Shares Owned By Institutions
N/A
40.87
85.39
N/A
N/A
N/A
N/A
N/A
N/A
0.84
Market Capitalization
3.13 M
375.23 M
17.06 B
2.69 K
96.58 K
50.36 M
N/A
N/A
N/A
233.49 M
Price To Earning
-0.01
11.42
-6.76
-2.93
-0.22
N/A
35.48
26.83
18.25
N/A
Price To Sales
N/A
13.76
7.94
0.0216
N/A
N/A
1.23
N/A
1.57
N/A
Net Income
(10.58 M)
18.98 M
(124.78 M)
(3.6 M)
(627.79 K)
N/A
N/A
5.2 M
N/A
(3.15 B)
Shares Owned By Insiders
N/A
0.07
0.47
N/A
N/A
N/A
N/A
N/A
N/A
30.28
Revenue
N/A
22.86 M
2.15 B
67.87 K
N/A
N/A
N/A
393.49 M
N/A
(3.1 B)
Year To Date Return
N/A
N/A
N/A
N/A
N/A
10.42
6.59
N/A
-0.0211
N/A
Working Capital
(14.89 M)
20.98 M
236.95 M
(57 K)
(794 K)
N/A
N/A
N/A
N/A
N/A
Profit Margin
N/A
0.79
-0.0581
N/A
N/A
N/A
N/A
0.0094
N/A
N/A
Current Valuation
6.59 M
279.32 M
16.68 B
2.07 K
912.76 K
N/A
N/A
535.95 M
N/A
103.84 M
Price To Book
53.19
3.94
N/A
N/A
N/A
N/A
1.58
N/A
2.13
0.005
Retained Earnings
(104.87 M)
20.98 M
(4.85 B)
(2.39 M)
(4.18 M)
N/A
N/A
N/A
N/A
N/A
Current Asset
942 K
15.09 M
329.86 M
450 K
N/A
N/A
N/A
N/A
N/A
N/A
Cash Position Weight
N/A
N/A
N/A
N/A
N/A
14.28
6.56
N/A
7.22
N/A
Equity Positions Weight
N/A
N/A
N/A
N/A
N/A
61.63
0.07
N/A
38.52
N/A
Shares Outstanding
68.27 M
13.12 M
267.93 M
4.14 K
965.83 K
N/A
N/A
N/A
N/A
6.11 B
Annual Yield
N/A
0.0586
N/A
N/A
N/A
0.0204
0.0612
0.0972
0.0206
N/A
Return On Equity
N/A
1.3
N/A
N/A
N/A
N/A
N/A
0.017
N/A
-0.5
Z Score
-63.3
N/A
N/A
-26.8
N/A
N/A
N/A
1.0
N/A
N/A
Book Value Per Share
-0.12
1.6
-2.75
-0.003
-1.18
N/A
N/A
3.66
N/A
0.89
Number Of Shares Shorted
N/A
426 K
6.98 M
N/A
N/A
N/A
N/A
4.29 K
N/A
N/A
Minimum Initial Investment
N/A
N/A
N/A
N/A
N/A
N/A
2 K
N/A
N/A
N/A
Total Asset
3.48 M
26.69 M
2.14 B
450 K
3.19 K
215.11 M
347.66 M
355.28 M
1.03 B
6.31 B
Target Price
9.0
33.0
82.36
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
N/A
0.02
0.73
0.14
N/A
Price To Earnings To Growth
N/A
N/A
2.09
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Earnings Per Share
-0.031
7.0
-0.34
-0.028
-0.63
N/A
N/A
1.17
N/A
N/A
Ten Year Return
N/A
N/A
N/A
N/A
N/A
N/A
6.0
N/A
5.76
N/A
Cash And Equivalents
178
13.97 M
1.32 B
26.83 K
1.15 K
N/A
N/A
51.31 M
N/A
N/A
Cash Per Share
N/A
1.97
5.83
N/A
N/A
N/A
N/A
3.23
N/A
N/A
Gross Profit
N/A
7.74 M
1.53 B
13.56 K
(143.88 K)
N/A
N/A
74.67 M
N/A
(4.09 B)
Day Typical Price
1.0E-4
28.59
62.64
1.0E-4
4.0E-4
10.83
4.21
23.57
12.1
0.036
Accumulation Distribution
N/A
0.0211
35173.93
N/A
N/A
N/A
N/A
22.8
N/A
N/A
Market Facilitation Index
N/A
0.61
0.0
N/A
N/A
N/A
N/A
0.0
N/A
N/A
Daily Balance Of Power
0.0
0.3934
(0.62)
(9,223,372,036,855)
(9,223,372,036,855)
9.2 T
(9,223,372,036,855)
(0.40)
9.2 T
9.2 T
Period Momentum Indicator
N/A
0.24
(1.14)
(0.0001)
(0.01)
0.02
(0.01)
(0.04)
0.06
0.026
Rate Of Daily Change
1.0
1.01
0.98
0.5
0.0667
1.0
1.0
1.0
1.0
3.6
Day Median Price
1.0E-4
28.59
62.7
1.0E-4
4.0E-4
10.83
4.21
23.56
12.1
0.036
Price Action Indicator
N/A
0.14
(0.74)
(0.00005)
(0)
0.01
(0.01)
N/A
0.03
0.013
Coefficient Of Variation
600.65
664.76
3967.28
1290.44
(812.40)
(746.81)
(1,627)
731.18
(745.63)
690.32
Mean Deviation
48.93
1.71
1.79
5.97
2.79
0.5385
0.1097
0.7636
0.2785
46.68
Jensen Alpha
21.08
0.3502
0.0423
1.52
(1.43)
(0.13)
(0.02)
0.1511
(0.07)
24.42
Total Risk Alpha
17.72
0.2851
(0.02)
0.9608
(1.74)
(0.16)
(0.03)
0.1158
(0.09)
19.43
Sortino Ratio
N/A
0.1524
0.0128
N/A
N/A
N/A
N/A
0.0965
N/A
N/A
Downside Variance
N/A
4.69
5.08
N/A
N/A
N/A
N/A
1.7
N/A
N/A
Standard Deviation
127.87
2.41
2.43
19.55
11.49
0.9247
0.1726
1.16
0.4757
166.15
Kurtosis
36.19
3.99
1.2
20.21
66.0
16.9
0.9557
5.69
19.72
61.03
Potential Upside
100.0
3.94
3.95
N/A
N/A
1.03
0.2364
2.0
0.4792
N/A
Treynor Ratio
2.36
4.05
0.1281
(2.31)
(19.59)
7.97
(1.13)
(1.06)
3.4
(1.47)
Maximum Drawdown
990.0
15.7
13.29
150.0
93.33
7.08
0.9445
4.9
3.47
1328.57
Variance
16349.47
5.8
5.88
382.28
131.99
0.855
0.0298
1.33
0.2263
27607.17
Market Risk Adjusted Performance
2.37
4.06
0.1381
(2.30)
(19.58)
7.98
(1.12)
(1.05)
3.41
(1.46)
Risk Adjusted Performance
0.1427
0.1266
0.0268
0.0714
(0.09)
(0.11)
(0.09)
0.1121
(0.11)
0.1254
Skewness
5.7
0.8033
(0.16)
3.47
(8.12)
(3.07)
(0.17)
(1.08)
(3.61)
7.72
Semi Deviation
N/A
1.89
2.15
N/A
N/A
N/A
N/A
1.03
N/A
N/A
Information Ratio
0.1662
0.1371
0.0119
0.0758
(0.13)
(0.17)
(0.25)
0.1089
(0.20)
0.1447
Value At Risk
(50.00)
(3.17)
(3.94)
N/A
N/A
(1.02)
(0.24)
(1.20)
(0.56)
N/A
Expected Short fall
N/A
(1.92)
(2.25)
N/A
N/A
N/A
N/A
(0.87)
N/A
N/A
Downside Deviation
N/A
2.17
2.25
N/A
N/A
N/A
N/A
1.3
N/A
N/A
Semi Variance
N/A
3.59
4.63
N/A
N/A
N/A
N/A
1.05
N/A
N/A

Amarantus Bioscience Competition Performance Charts

Five steps to successful analysis of Amarantus Bioscience Competition

Amarantus Bioscience's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Amarantus Bioscience in relation to its competition. Amarantus Bioscience's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Amarantus Bioscience in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Amarantus Bioscience's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Amarantus Bioscience, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Amarantus Bioscience position

In addition to having Amarantus Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Mid Cap ETFs Thematic Idea Now

Mid Cap ETFs
Mid Cap ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Mid Cap ETFs theme has 70 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Mid Cap ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Amarantus Pink Sheet Analysis

When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY